Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Reality in COPD Exacerbation

NCT: NCT05687396 · COMPLETED

NCT IDNCT05687396
StatusCOMPLETED
Start Date2022-06-01
Completion2024-04-22
SponsorPamukkale University (OTHER)
First posted
Last updated

Brief Summary

In addition to conventional pulmonary rehabilitation, virtual reality will be applied during the hospitalization period of individuals hospitalized for COPD exacerbation. It is aimed to get more efficiency from the interventions in this short time.

Frequently Asked Questions

What is Virtual Reality in COPD Exacerbation?

Virtual Reality in COPD Exacerbation is a clinical trial registered under NCT05687396. Current status: COMPLETED.

What is the status of NCT05687396?

The current status of NCT05687396 (Virtual Reality in COPD Exacerbation) is: COMPLETED.

When did Virtual Reality in COPD Exacerbation start?

Virtual Reality in COPD Exacerbation started on 2022-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.